Abstract
Aminoazaheterocycles are a group of organic molecules having an amino group attached to a carbon adjacent to a ring nitrogen in an aromatic system. The nucleic acid bases adenine, guanine, cytosine and the vitamin thiamine are examples of ortho-aminoazaheterocycles which exist naturally as essential compounds required for the proper physiological and biochemical function of biological systems. A large number of important medicinal agents covering a wide spectrum of pharmacological activities also belongs to this chemical group: e.g. the anti-anaemic, folic acid; the antimalarial, pyrimethamine; the broad spectrum antibacterials, trimethoprim and cefotaxime; the anticancer agent, metoprine; the diuretics, triamterene and amiloride (Fig. 10.1). Many aminoazaheterocycles are also in vivo metabolites of medicinal agents (Fig. 10.2). A number of known examples of aminoazaheterocycles, which are among the most mutagenic and carcinogenic compounds, are formed during the cooking process of foods and have been detected in charred meat, broiled fish and in pyrolysates of proteins and amino acids (Fig. 10.3), (Sugimura and Nagao, 1979; Sugimura and Sato, 1983).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bevan, A.W., Roberts, G.C.K., Feeney, J. and Kuyper, L. (1985) 1H NMR and 15N NMR studies of protonation and hydrogen—bonding in the binding of trimethoprim to dihydrofolate reductase. Eur. Biophys. J., 11, 211–18.
Brooks, M.A., de Silver, J.A.F. and D'Arconte, L. (1973) Determination of trimethoprim and its N-oxide metabolites in man, dog, and rat by differential pulse polarography. J. Pharm. Sci., 62, 1776–9.
Cheung, H.T.A., Searle, M.S., Feeney, J. et al. (1986) Trimethoprim binding to Lactobacillus casei dihydrofolate reductase: a 13C NMR study using selectively 13C-enriched trimethoprim. Biochemistry, 25, 1925–31.
El-Ghomari, K. (1988) The metabolic N-oxidation of aminoazaheterocycles, PhD Thesis, University of London.
El-Ghomari, K. and Gorrod, J.W. (1987) Metabolic TV-oxygenation of 2,4-diamino-6-substituted pyrimidines. Eur. J. Drug Metab. Pharmacokinet, 12, 253–8.
Felton, J.S., Knize, M.G., Shen, N.H. et al. (1986) The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP). Carcinogenesis, 7, 1081–6.
Felton, J.S., Knize, M.G., Wood, C. et al. (1984) Isolation and characterization of new mutagens from fried ground beef. Carcinogenesis, 5, 95–102.
Gorrod, J.W. (1973) Differentiation of various types of biological oxidation of nitrogen in organic compounds. Chem. Biol. Interact., 7, 289–303.
Gorrod, J.W. (1978) The current status of pK a concepts in the differentiation of enzymic N-oxidation, in Biological Oxidation of Nitrogen (ed. J.W. Gorrod), Elsevier, Amsterdam, pp. 201–10.
Gorrod, J.W. (1985) Amine-imine tautomerism as a determinant of the site of biological N-oxidation, in Biological Oxidation of Nitrogen in Organic Molecules (eds J.W. Gorrod and L.A. Damani), Ellis Horwood, Chichester, pp. 219–30.
Gorrod, J.W. (1987) The in vitro metabolism of aminoazaheterocycles, in Drug Metabolism from Molecules to Man (eds D.J. Benford, J.W. Bridges and G.G. Gibson), Taylor and Francis, London, pp. 456–61.
Gorrod, J.W. and Lam, S.P. (1989) Amino azaheterocycles: friend or foe? in Molecular Aspects of Human Disease (eds J.W. Gorrod, O. Albano and S. Papa), Ellis Horwood, Chichester, Vol. 2, pp. 100–12.
Gorrod, J.W. and Lam, S.P. (1990) Microsomal cytochrome P-450 mediated N-oxygenation of aminoazaheterocycles, in Biological Oxidation Systems (eds C.C. Reddy, G.A. Hamilton and K.M. Madyastha), Academic Press, San Diego, 1, 147–62.
Hammond, S.J., Birdsall, B., Feeney, J. et al. (1987) Structural comparisons of complexes of methotrexate analogues with Lactobacillus casei dihydrofolate reductase by two-dimensional 1H NMR at 500 MHz, Biochemistry, 26, 8585–90.
Hashimoto, Y., Shudo, K. and Okamoto, T. (1980a) Activation of a mutagen, 3-amino-1-methyl-5H-pyrido[4,3-b]indole. Identification of 3-hydroxyamino-1-methyl-5H-pyrido[4,3-b]indole and its reaction with DNA. Biochem. Biophys. Res. Commun., 96, 355–62.
Hashimoto, Y., Shudo, K. and Okamoto, T. (1980b) Metabolic activation of a mutagen, 2-amino-6-methyldipyrido[l,2-a: 3′,2′-d]imidazole. Identification of 2-hydroxyamino-6-methyldipyrido[l,2-a: 3′,2,-d]imidazole and its reaction with DNA. Biochem. Biophys. Res. Commun., 92, 971.
Hubbel, J.P., Henning, M.L., Grace, M.E. et al. (1978) N-Oxide metabolites of 2,4-diaminopyrimidine inhibitors of dihydrofolate reductase, trimethoprim, pyrimethamine and metoprine, in Biological Oxidation of Nitrogen (ed. J.W. Gorrod), Elsevier, Amsterdam, pp. 177–82.
Hubbel, J.P., Kao, C.J., Sigel, C.W. and Nichol, C.A. (1980) Sex dependent disposition of metoprine by mice, in Current Chemotherapy and Infectious Disease (eds J.D. Nelson and C. Grassi), American Society for Microbiology, Washington, DC, pp. 1620–1.
Iles, N. (1988) Biological N-oxidation of isomeric aminopyridines, PhD Thesis, University of London.
Ishida, Y., Negishi, C, Umemoto, A. et al. (1987) Activation of mutagenic and carcinogenic heterocyclic amines by S-9 from the liver of a rhesus monkey. Toxic. in Vitro, 1,45–8.
Kamataki, T., Maeda, K., Yamazoe, Y. et al. (1983) A high spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Mol. Pharmacol., 24, 146–55.
Kato, R. (1986) Metabolic activation of mutagenic heterocyclic aromatic amines from protein pyrolysates. CRC Crit. Rev. Toxicol., 16, 307–47.
Kato, R., Kamataki, T. and Yamazoe, Y. (1983) N-Hydroxylation of carcinogenic and mutagenic aromatic amines. Environ. Health Perspect., 49, 21–5.
Kawajiri, K., Yonehawa, H., Gotoh, O. et al. (1983) Contributions of two inducible forms of cytochrome P-450 in rat liver microsomes of the metabolic activation of various chemical carcinogens. Cancer Res., 43, 819–23.
Lam, S.P. (1989) Influence of 9-substitution on the microsomal N-oxidation of adenine, PhD Thesis, University of London.
Lam, S.P., Barlow, D.J. and Gorrod, J.W. (1989) Conformational analysis of 9-substituted adenines in relation to their microsomal 1-N-oxidation. J. Pharm. Pharmacol., 41, 373–8.
Lam, S.P., Devinsky, F. and Gorrod, J.W. (1987) Biological N-oxidation of adenine and 9-alkyl derivatives. Eur. J. Drug Metab. Pharmacokinet., 12, 239–43.
Meshi, T. and Sato, Y. (1972) Studies on sulfamethoxazole/trimethoprim. Absorption, distribution, excretion and metabolism of trimethoprim in rat. Chem. Pharm. Bull. (Japan), 20, 2079–90.
Nagao, N., Fujita, Y., Wakabayashi, K. and Sugimura, T. (1983) Ultimate forms of mutagenic and carcinogenic heterocyclic amines produced by pyrolysis. Biochem. Biophys. Res. Commun., 114, 626–31.
Negishi, C, Wakabayashi, K., Tsuda, M. et al. (1984) Formation of 2-amino-3,7,8-trimethylimidazo[4,5-f]quinoxaline, a new mutagen, by heating a mixture of creatinine, glucose and glycine. Mutat. Res., 140, 55–9.
Nemoto, N., Kusumi, S., Takayama, S. et al. (1979) Metabolic activation of 3-amino-5H-pyrido[4,3-b]indole, a highly mutagenic principle in tryptophan pyrolysate, by rat liver enzymes. Chem. Biol. Interact., 27, 191–8.
Nichol, C.A., Cavallito, J.C, Wooley, J.L. and Sigel, C.W. (1977) Lipid-soluble diaminopyrimidine inhibitors of dihydrofolate reductase. Cancer Treat. Rep. 61, 559.
Okamoto, T., Shudo, K., Hashimoto, Y. et al. (1981) Identification of a reactive metabolite of the mutagen, 2-amino-3-methylimidazo[4,5-f]quinoline. Chem. Pharm. Bull., 29, 590.
Ryan, D.E., Thomas, P.E., Karzenlowski, D. and Levin, W. (1979) Separation and characterization of highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3-methyl-cholanthrene. J. Biol. Chem. 254, 1365–74.
Schwartz, D.E., Vetter, W. and Englert, G. (1970) Trimethoprim metabolites in rat, dog and man: qualitative and quantitative studies. Arzneim. Forsch., 20, 1867.
Searle, M.S., Forster, M.J., Birdsall, B. et al. (1988) Dynamics of trimethoprim bound to dihydrofolate reductase. Proc. Natl. Acad. Sci. USA, 85, 3787–91.
Sigel, C.W. (1973) Metabolism of trimethoprim in man and measurement of a new metabolite: a new fluorescence assay. J. Infect. Dis. Suppl., 128, 580–3.
Sigel, C.W. and Brent, D.A. (1973) Identification of trimethoprim 3-N-oxide as a new urinary metabolite of trimethoprim in man. J. Pharm. Sci., 62, 694–5.
Sugimura, T. and Nagao, M. (1979) Mutagenic factors in cooked foods. CRC Crit. Rev. Toxicol., 8, 189–209.
Sugimura, T. and Sato, S. (1983) Mutagens-carcinogens in foods. Cancer Res., 43, 2415s–21s.
Sugimura, T., Kawachi, T., Nagao, M. et al. (1977) Mutagenic principle(s) in tryptophan and phenylalanine pyrolysis products. Proc. Jpn. Acad., 53, 58–61.
Thomas, R.C. and Hartpoolian, H. (1975) Metabolism of minoxidil, a new hypotensive agent II: biotransformation following oral administration to rats, dogs and monkeys. J. Pharm. Sci., 64, 1366–71.
Wang, C.C. and Simashkevich, P.M. (1980) A comparative study of the biological activities of arprinocid and arprinocid-1-N-oxide. Mol. Biochem. Parasitol., 1, 335–45.
Watkins, P.J. (1988) Biological N-oxidation of some substituted 2,4-diamino-pyrimidines, PhD Thesis, University of London.
Watkins, P.J. and Gorrod, J.W. (1987) Studies on the in vitro biological N-oxidation of trimethoprim. Eur. J. Drug Metab. Pharmacokinet., 12, 245–51.
Wolf, F.J., Steffens, J.J., Alvaro, R.F. and Jacob, T.A. (1978) Microsomal conversion of MK-302, arprinocid [6-amino-9-(2-chloro-6-fluorobenzyl)purine] to 6-amino-9-(2-chloro-6-fluorobenzyl)purine-1-N-oxide by liver microsomes from the chicken and the dog and to the 2-chloro-6-fluorobenzyl alcohol by liver microsomes from rat and mouse. Fed. Proc., 37, 814.
Yamamoto, T., Tsuji, K., Kosuge, T. et al. (1978) Isolation and structure determination of mutagenic substances in L-glutamic acid pyrolysate. Proc. Jpn Acad., 54, 248–50.
Yamazoe, Y., Ishii, K., Kamataki, T. et al. (1980) Isolation and characterization of active metabolites of tryptophan-pyrolysate mutagen, Trp-P-2, formed by rat liver microsomes. Chem. Biol. Interact., 30, 125–38.
Yamazoe, Y., Shimada, M., Maeda, K. et al. (1984) Specificity of four forms of cytochrome P-450 in the metabolic activation of several aromatic amines and benzo[a]pyrene. Xenobiotica, 14, 549–52.
Zins, G.R. (1965) The in vivo production of a potent, long acting hypotensive metabolite from diallylmelamine. J. Pharmacol. Exp. Ther., 150, 109–17.
Zins, G.R., Emmert, D.W. and Walker, R.A. (1968) Hypotensive metabolite production and sequential metabolism of N,N-diallymelamine in rats, dogs and man. J. Pharmacol. Exp. Ther., 159, 194–205.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Gorrod, J.W., Lam, S.P. (1991). The role of cytochrome P-450 in the biological nuclear N-oxidation of aminoaza-heterocyclic drugs and related compounds. In: Hlavica, P., Damani, L.A. (eds) N-Oxidation of Drugs. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3112-4_10
Download citation
DOI: https://doi.org/10.1007/978-94-011-3112-4_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5378-5
Online ISBN: 978-94-011-3112-4
eBook Packages: Springer Book Archive